en English
Human Development
Mar 2, 2026
Christopher Marquis
With a hostile political atmosphere making investors increasingly wary of vaccine-related research in the US, firms are winding down development programs, shelving manufacturing plans, and laying off workers. While these responses are understandable, they are short-sighted.







